CureVac NV
NASDAQ:CVAC

Watchlist Manager
CureVac NV Logo
CureVac NV
NASDAQ:CVAC
Watchlist
Price: 3.21 USD 2.88% Market Closed
Market Cap: 720.1m USD

Intrinsic Value

CVAC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CVAC stock under the Base Case scenario is 9.94 USD. Compared to the current market price of 3.21 USD, CureVac NV is Undervalued by 68%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CVAC Intrinsic Value
9.94 USD
Undervaluation 68%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
CureVac NV

CVAC
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CVAC cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

CureVac NV
NASDAQ:CVAC
DE
Biotechnology
Market Cap
720.1m USD
IPO
Aug 14, 2020
DE
Biotechnology
Market Cap
720.1m USD
IPO
Aug 14, 2020
Price
$false
EPS
€false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CVAC?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about CureVac NV
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
CureVac NV

Current Assets 526.4m
Cash & Short-Term Investments 485.4m
Receivables 22.6m
Other Current Assets 18.4m
Non-Current Assets 276.4m
PP&E 244.7m
Intangibles 25.2m
Other Non-Current Assets 6.6m
Efficiency

Free Cash Flow Analysis
CureVac NV

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
CureVac NV

Revenue
535.2m EUR
Cost of Revenue
-105.8m EUR
Gross Profit
429.4m EUR
Operating Expenses
-251.7m EUR
Operating Income
177.7m EUR
Other Expenses
-15.5m EUR
Net Income
162.2m EUR
Fundamental Scores

CVAC Profitability Score
Profitability Due Diligence

CureVac NV's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional ROIC
Exceptional 1-Year Revenue Growth
ROE is Increasing
33/100
Profitability
Score

CureVac NV's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

CVAC Solvency Score
Solvency Due Diligence

CureVac NV's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

CureVac NV's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CVAC Price Targets Summary
CureVac NV

Wall Street analysts forecast CVAC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CVAC is 7.87 USD with a low forecast of 2.53 USD and a high forecast of 16.8 USD.

Lowest
Price Target
2.53 USD
21% Downside
Average
Price Target
7.87 USD
145% Upside
Highest
Price Target
16.8 USD
423% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

CureVac NV
does not pay dividends
Shareholder Yield

Current shareholder yield for CVAC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

CVAC News

Other Videos
What is the Intrinsic Value of one CVAC stock?

The intrinsic value of one CVAC stock under the Base Case scenario is 9.94 USD.

Is CVAC stock undervalued or overvalued?

Compared to the current market price of 3.21 USD, CureVac NV is Undervalued by 68%.

Back to Top